- Trials with a EudraCT protocol (641)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (34)
641 result(s) found for: Affect.
Displaying page 1 of 33.
| EudraCT Number: 2008-002335-32 | Sponsor Protocol Number: AN08/8505 | Start Date*: 2008-11-28 |
| Sponsor Name:The University of Leeds | ||
| Full Title: Does concentration affect the ED50 of bupivacaine for supraclavicular brachial plxus block? | ||
| Medical condition: Not applicable | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-001012-19 | Sponsor Protocol Number: CFTY720DNL02T | Start Date*: 2014-12-17 |
| Sponsor Name:VU University Medical Center | ||
| Full Title: Effects of fingolimod on functional brain adaptation and clinical measures in multiple sclerosis | ||
| Medical condition: Relapsing-remitting (RR) multiple sclerosis (MS) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-004920-40 | Sponsor Protocol Number: AFFECT | Start Date*: 2021-03-22 |
| Sponsor Name:Vestre Viken HF | ||
| Full Title: Affective effects of pre-surgery opioids (AFFECT): a randomized double-blind controlled trial | ||
| Medical condition: Healthy adult surgery patients. Health status ASA1 or ASA2 as categorised by a medical doctor at the hospital based on medical history, physical examination. The American Society of Anesthesiologis... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NO (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2018-003556-20 | Sponsor Protocol Number: 1806-LIS-044-SD | Start Date*: 2019-06-17 |
| Sponsor Name:INSTITUTO VALENCIANO DE INFERTILIDADE - CLÍNICA DE REPRODUÇÃO ASSISTIDA, LDA | ||
| Full Title: How do different ovarian stimulation protocols affect endometrial receptivity during a fresh in vitro fertilization attempt? | ||
| Medical condition: Women with a clinical indication to undergo Assisted Reproductive Technologies for infertility with a predicted normal response to Ovarian Stimulation and planned for a single blastocyst transfer | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: PT (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001000-42 | Sponsor Protocol Number: 1144/2020 | Start Date*: 2020-07-09 |
| Sponsor Name:Medical University of Vienna | ||
| Full Title: The relationship of cholesterol-lowering drugs with steroid HORMONEs, bile acids, vitamin D, the immune system and related diseases such as depression and osteoporosis | ||
| Medical condition: Patients with a diagnosed hyperlipidemia treated with statins (with either simvastatin <=20 mg, atorvastatin <=10 mg or rosuvastatin <=10 mg - random allocation), or with atorvastatin >=40 mg or r... | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Trial now transitioned) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2011-000753-24 | Sponsor Protocol Number: DC2011LiBrain001 | Start Date*: 2011-10-13 | ||||||||||||||||
| Sponsor Name:VU University Medical Center | ||||||||||||||||||
| Full Title: Central effects of endogenous GLP-1 and the GLP-1 analog liraglutide on brain satiety and reward circuits and feeding behavior in diabetes. | ||||||||||||||||||
| Medical condition: diabetes mellitus obesity | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults | Gender: Male, Female | |||||||||||||||||
| Trial protocol: NL (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2006-005649-12 | Sponsor Protocol Number: SUCPAT1_CTR0026 | Start Date*: 2006-12-20 |
| Sponsor Name:Regent Medical | ||
| Full Title: A 96 hour (4-application) patch test and TEWL assessment in healthy volunteers to investigate the comparative skin irritation potential of six antiseptics and two controls following cutaneous patch... | ||
| Medical condition: This trial will be carried out on healthy volunteers. Patches containing 0.2mls of each test product will be used. Each volunteer will have a single patch per product and the patches will be remov... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-000506-11 | Sponsor Protocol Number: Lx-Gf01 | Start Date*: 2017-06-06 |
| Sponsor Name:Limoxifen BV | ||
| Full Title: Proof-of-concept study on treating cognitive side-effects of Tamoxifen with guanfacine in postmenopausal women with E2/Pg receptor-positive breast cancer. | ||
| Medical condition: Memory loss, attention deficit | ||
| Disease: | ||
| Population Age: Adults | Gender: Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001055-35 | Sponsor Protocol Number: 06/MREC09/30 | Start Date*: 2006-10-16 |
| Sponsor Name:Imperial College London | ||
| Full Title: Lapatinib Pre-Surgical Phase 2 Study in Patients with Primary Breast Cancer | ||
| Medical condition: Patients with primary breast cancer and new primary or recurrent breast cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Female | |
| Trial protocol: GB (Prematurely Ended) | ||
| Trial results: Removed from public view | ||
| EudraCT Number: 2005-000496-17 | Sponsor Protocol Number: 010 | Start Date*: 2006-10-06 |
| Sponsor Name:Region Skåne | ||
| Full Title: Atorvastatin in moderat active Crohns disease | ||
| Medical condition: Crohn's disease is an idiopathic chronic inflammatory bowel disease thought to result from inappropriate and ongoing activation of the mucosal immune system driven by the presence of normal luminal... | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002338-39 | Sponsor Protocol Number: 17 | Start Date*: 2006-12-22 |
| Sponsor Name:Universitätsklinikum Heidelberg | ||
| Full Title: Pharmakokinetik von Linezolid bei Dialyse (pharmacokinetics of linezolid under dialysis) | ||
| Medical condition: acute renal failure and infection or sepsis without acute renal failure | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-000294-29 | Sponsor Protocol Number: PLD-Caps_Protocol-V1.0 | Start Date*: 2007-04-20 |
| Sponsor Name:Department of Dermatology, medical University of Graz | ||
| Full Title: Die Bedeutung des sensorischen Nervensystems der Haut bei polymorpher Lichtdermatose English title: The role of the cutaneous sensory nervous system in polymorphic light eruption (PLE) | ||
| Medical condition: Polymorphic light eruption | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: AT (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2006-003013-41 | Sponsor Protocol Number: BKR-KNAST-06 | Start Date*: 2006-07-13 |
| Sponsor Name:Children's Clinic Randers | ||
| Full Title: Short-term and longterm growth in children with asthma treated with budesonide or montelukast | ||
| Medical condition: asthma | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-002192-40 | Sponsor Protocol Number: periodld001 | Start Date*: 2006-07-13 |
| Sponsor Name:Zsolt Lohinai DMD PhD | ||
| Full Title: New treatment of periodontitis by inhibition of lysine decarboxilase enzyme | ||
| Medical condition: healthy volunteers | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: HU (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-005534-15 | Sponsor Protocol Number: PRO-GLY-002/E2013 | Start Date*: 2021-04-01 |
| Sponsor Name:Proveca Pharma LTD | ||
| Full Title: Double-blind, placebo-controlled, randomized clinical trial comparing the efficacy and safety of Sialanar plus oral rehabilitation against placebo plus oral rehabilitation for children and adolesce... | ||
| Medical condition: Severe sialorrhoea and neurodisabilties in children | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: FR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2006-001251-35 | Sponsor Protocol Number: 2006/01 | Start Date*: 2006-07-03 |
| Sponsor Name:Aalborg University | ||
| Full Title: TO STUDY THE PERIPHERAL EFFECT OF BOTULINUM TOXIN-A (BOTOX-A) ON EXPERIMENTALLY INDUCED CUTANEOUS PAIN IN HEALTHY SUBJECTS | ||
| Medical condition: There is no medical condition- the study is done on healthy humans. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2019-000309-64 | Sponsor Protocol Number: AL-ACC-01 | Start Date*: 2019-10-24 | |||||||||||
| Sponsor Name:Ayala Pharmaceuticals, Inc. | |||||||||||||
| Full Title: A Phase 2, Open-Label, Multi-Center Study of AL101 in Patients With Adenoid Cystic Carcinoma (ACC) Bearing Activating Notch Mutations | |||||||||||||
| Medical condition: Adenoid cystic carcinoma | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (GB - no longer in EU/EEA) FR (Completed) NL (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2011-002185-21 | Sponsor Protocol Number: 11GS005 | Start Date*: 2011-09-15 | |||||||||||
| Sponsor Name:Research and Development Nottingham University Hospital | |||||||||||||
| Full Title: An open label study to determine the efficacy of ferric carboxymaltose in preoperative colorectal cancer related anaemia, and to develop biomarkers to predict response to this treatment strategy | |||||||||||||
| Medical condition: The medical condition to be investigated is anaemia (low blood count) in pre-operative patients with colorectal cancer. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-012676-27 | Sponsor Protocol Number: FemExp-I | Start Date*: 2010-01-24 | ||||||||||||||||
| Sponsor Name:Wallenberg laboratory | ||||||||||||||||||
| Full Title: Femoral-Express-I | ||||||||||||||||||
| Medical condition: Peripheral artery disease. Patients due for by-pass surgery of lower extremity arteries. | ||||||||||||||||||
|
||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
| Trial protocol: SE (Ongoing) | ||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||
| EudraCT Number: 2014-000975-21 | Sponsor Protocol Number: RET-AFLI-2014-01 | Start Date*: 2014-06-16 |
| Sponsor Name:Fundación Retinaplus + | ||
| Full Title: A phase IV study to evaluate the effectiveness of aflibercept in naive patients with macular edema secondary to Central Retinal Vein Occlusion (CRVO) on an individualized Treat and Extend regimen. ... | ||
| Medical condition: Macular edema secondary to central retinal vein occlusion. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: ES (Completed) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.
